|Podcasts|June 18, 2009

Rewards for Subjects, an Ethical Dilemma?

Rewards for Subjects, an Ethical Dilemma?

Felix Gyi, PharmD, MBA, CEO of Chesapeake Research Review discusses ethical rewards for patients in clinical studies and how the relationships between pharma and health care professionals affects subject recruitment and retention.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Rewards for Subjects, an Ethical Dilemma?

Related Content

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit

Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development

The Evolving Relationship Between Sponsors and the Contract Research Organizations

The MDR: Navigating Europe’s New Standard for Medical Device Safety

Trending on Applied Clinical Trials Online

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway

Where AI Is Delivering Real Value in Clinical Trial Payments Right Now

ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems

From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance

ACT Brief: Payment Infrastructure and Site Cash, Inspection Readiness Throughout Execution, and First Hemolytic Anemia Therapy